TSX-V: CHO
www.chinahealthlabs.com
Financial Results for the First Quarter Ended March 31, 2013 to be Released on May 30, 2013
TORONTO,
May 29, 2013 /CNW/ - China Health
Labs & Diagnostics Ltd. ("China Health" or the "Company")
(TSXV: CHO), is pleased to announce that on May 30, 2013, after market close, it will be
releasing the results of the first quarter ended March 31, 2013, and will be hosting an investor
conference call on Friday, May 31,
2013 at 10:00am (Eastern
Time). The purpose of this conference call will be to
provide investors with an update of the first quarter results of
the Company. Representing China Health on the conference call
will be:
|
|
|
|
|
Mr. Shiping (Wilson) Yao, President and Chief Executive
Officer
Ms. Judyanna Chen, Chief Financial Officer
Mr. Chao Zhang, Vice President, Finance (Chief Financial Officer,
effective May 31, 2013)
Mr. Kim Oishi, Member of the Board of Directors |
Following the update, a question and answer
session will be held. To participate, the dial-in
instructions are as follows:
DATE: |
Friday, May 31, 2013
|
TIME: |
10:00am, Eastern Time |
Participant Dial-In Number(s): |
|
North America Toll-Free Dial-In Number: |
1 (888) 231-8191 |
|
For Toronto and International Callers: |
1 (647) 427-7450 |
A Taped Replay will be available from 1:00
pm Eastern Time on May 31,
2013 to 11:59 pm Eastern Time
on June 14, 2013.
Taped Replay Toll Free Number:
1.855.859.2056
Taped Replay Local Dial-in Numbers:
|
(778) 371-8506 |
(416) 849-0833 |
(514) 807-9274 |
(403) 451-9481 |
(613) 667-0035 |
(902) 455-3955 |
Taped Replay Password: 86571508
About China Health Labs & Diagnostics
Ltd.
China Health, operating in China as the Biochem Group, is a leading
diagnostic lab solution provider for the public healthcare industry
in China. The Company develops and
sells Biochem Group branded and third-party medical diagnostic
products and services to diagnostic facilities in China. Customers include large urban
hospitals, rural hospitals, Chinese military and rescue operations,
the Beijing government and
third-party distributors.
In 2012, China Health had revenue of
approximately $45.8 million, and
intends to expand its business by focusing its efforts on expanding
its sales network in three areas where it provides proprietary
solutions, has limited competition and that are supported by
Chinese government policy and budgets: BK Clinlab total lab
solutions for rural hospitals and clinics, POCT solutions for
military and emergency rescue services, and food safety solutions
for large cities in China.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This news release contains forward-looking
statements and information that are based on the beliefs of
management and reflect China Health's current expectations. When
used in this news release, the words "estimate", "project",
"belief", "anticipate", "intend", "expect", "plan", "predict",
"may" or "should" and the negative of these words or such
variations thereon or comparable terminology are intended to
identify forward-looking statements and information. The
forward-looking statements and information in this news release
includes information relating to the expansion of the Company's
business by focusing on expanding its sales network to additional
Chinese provinces and cities in the areas where it has proprietary
products, limited competition and strong government support.. The
forward-looking information is based on certain assumptions, which
could change materially in the future, including the assumption
that the Company's products and services, operations, market,
marketing plans and strategies, competitive conditions, future
developments and proprietary protections continue as projected.
Such statements and information reflect the current view of China
Health with respect to risks and uncertainties that may cause
actual results to differ materially from those contemplated in
those forward-looking statements and information. By their nature,
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause our actual results,
performance or achievements, or other future events, to be
materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. Such factors include, among others, the risk that the
Company may not be able to expand its business as expected through
its sales network in any of the areas in which it has proprietary
products, limited competition and strong government support. These
and other risks are further described under "Risk Factors" in the
Company's management's discussion and analysis dated April 30, 2013, which is available on SEDAR and
may be accessed at www.sedar.com. When relying on China Health's
forward-looking statements and information to make decisions,
investors and others should carefully consider the foregoing
factors and other uncertainties and potential events. China Health
has assumed a certain progression, which may not be realized. It
has also assumed that the material factors referred to above will
not cause such forward-looking statements and information to differ
materially from actual results or events. However, the list of
these factors is not exhaustive and is subject to change and there
can be no assurance that such assumptions will reflect the actual
outcome of such items or factors.
THE FORWARD-LOOKING INFORMATION CONTAINED IN
THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH AS OF THE DATE OF THIS NEWS
RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH
DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON
FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS
INFORMATION AS OF ANY OTHER DATE. WHILE CHINA HEALTH MAY ELECT TO, IT DOES NOT
UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT
AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
SOURCE CHINA HEALTH LABS &
DIAGNOSTICS